• 5:44 - 7:14
Broadcast Of 2021 – Dr. Peter McCullough Live In Studio & More - “This is a Test of Scientific Integrity” Must See Comprehensive Data Transparency
Monoclonal Antibodies, GlaxoSmithKline Sotirivumab and Florida Surgeon General
Florida Surgeon General Joe Ladepo is seeking increased access to GlaxoSmithKline's monoclonal antibody treatment, Sotirivumab, which remains effective against the Omicron variant. Other treatments like Regeneron and Eli Lilly products have been set aside as they are less effective against new mutations. There are allegations that the federal government is blocking the distribution of these life-saving treatments to specific states.